🔎 Trials Near Me

Home › Non-Small Cell Lung Cancer › Massachusetts › Somerville

Non-Small Cell Lung Cancer clinical trials in Somerville, MA

6 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Somerville (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

RecruitingPhase 3
  • Lahey Clinic, Burlington · 9 mi away
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT04267848

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

RecruitingPhase 3
  • Lahey Clinic, Burlington · 9 mi away
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06498635

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

RecruitingPhase 3
  • Lahey Hospital & Medical Center, Burlington · 9 mi away
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06890598

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

RecruitingPhase 3
  • Lahey Hospital & Medical Center, Burlington · 9 mi away
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

RecruitingPhase 2
  • Lahey Hospital and Medical Center, Burlington · 9 mi away
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT06116682

Non-Small Cell Lung Cancer trials in other cities

Other studies in Somerville

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.